Coronary Vasospasm and Myocardial Infarction Induced by Oral Sumatriptan
Authors:
- Sanjeev WassonSWSanjeev Wasson
- Vinod K. S JayamVJVinod K. S Jayam
- 1 July 2004
- journal article
- case report
- Published by Wolters Kluwer Health in Clinical Neuropharmacology
- Vol. 27 (4) , 198-200
Abstract
Coronary vasospasm is well documented as a side effect of injectable subcutaneous forms of sumatriptan; only one such case has been reported so far with oral ingestion of sumatriptan in a patient with underlying coronary artery disease. This report describes a case of coronary vasospasm induced by oral sumatriptan even in normal coronary arteries. Physicians and patients should be aware of a small and unpredictable risk of the serious cardiac side effects of this drug.Keywords
This publication has 11 references indexed in Scilit:
- Cardiac Arrest and Myocardial Infarction Immediately after Sumatriptan InjectionAnnals of Internal Medicine, 1998
- 5-HT1Dβ Receptor Mediates the Supersensitivity of Isolated Coronary Artery to Serotonin in Variant AnginaChest, 1998
- Sumatriptan in clinical practiceNeurology, 1996
- Drug treatment of migraineCurrent Opinion in Neurology, 1996
- Oral sumatriptan-associated transmural myocardial infarctionNeurology, 1995
- Postmarketing study of cardiovascular adverse reactions associated with sumatriptan.BMJ, 1993
- Effect of subcutaneous sumatriptan, a selective 5HT1 agonist, on the systemic, pulmonary, and coronary circulation.Circulation, 1993
- Coronary vasospasm and sumatriptan.BMJ, 1992
- Coronary vasospasm induced by subcutaneous sumatriptan.BMJ, 1992
- Treatment of Migraine Attacks with SumatriptanNew England Journal of Medicine, 1991